Literature DB >> 4829861

Comparison of the renin response to dopamine and noradrenaline in normal subjects and patients with autonomic insufficiency.

C S Wilcox, M J Aminoff, A B Kurtz, J D Slater.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4829861     DOI： 10.1042/cs0460481

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN： 0301-0538


× No keyword cloud information.
  8 in total

1.  The effects of intravenous L-dopa on plasma renin activity, renal function, and blood pressure in man.

Authors:  D Worth; J Harvey; J Brown; M Lee
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.

Authors:  D P Worth; J N Harvey; J Brown; A Worral; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

3.  The effect of dopamine administration on the activity of the renin-angiotensin-aldosterone system in sick preterm infants.

Authors:  E Sulyok; I Seri; T Tulassay; J Kiszel; T Ertl
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

4.  The effects of dopamine on renin release in the isolated perfused rat kidney.

Authors:  T Quesada; L Garcia-Torres; F Alba; C Garcia del Rio
Journal:  Experientia       Date:  1979-09-15

Review 5.  Effect of antihypertensive drugs on the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Effect of low-dose dopamine infusion on urinary prostaglandin E2 excretion in sick, preterm infants.

Authors:  I Seri; J Hajdu; J Kiszel; T Tulassay; A Aperia
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

7.  Clonidine withdrawal. Mechanism and frequency of rebound hypertension.

Authors:  G G Geyskes; P Boer; E J Dorhout Mees
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

8.  The use of bromocriptine for testing central dopaminergic reactivity.

Authors:  H Allain; J M Reymann; D Bentue-Ferrer; D Pape; J van den Driessche; O Sabouraud
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.